Foley Partner Mark Waxman authored an article titled "Scientific Responsibility in the Age of Bioterror" in the July 8, 2008 issue of Drug Discovery & Development. Waxman gave his insight into the emergence of synthetic biology, adding that the developing platform has the potential to create a new breed of industry as well as new security challenges.